Ramp3, Sema4c, Rin1, Acvr1, Iqck, Tagln3, Scg5, Cacna2d4, and Peg3 were downregulated with AD onset and were reversed to upregulated in expression following CBD treatment. This evidence concerns the gene PEG3 and Alzheimer disease.